Endoscopic Sinus Surgery (FESS) Success Rate in New Delhi
Access high-quality treatment through JCI & NABH-accredited hospitals, renowned specialists, and end-to-end medical travel support designed around your healing journey.
Plan My Journey
Tell us your condition and budget - our AI matches the right destination, hospital and doctor and visa pathway
Cost calculator
I know my treatment - show me cost from 3 hospitals
5K+ International Patients Treated
40+ Source Countries Served
500+ Accredited Partner Hospitals
98% Patient Satisfaction
80% Average Savings vs USA
10K+ Doctors
NABH, JCI Accredited Hospitals
Free Treatment Plan
Free Consultation with Doctor
5+ Destinations Covered
Written by DivinHeal Editorial Contributor, DivinHeal Medical Team, Healthcare Advisory Team Published on: February 19, 2026
About
Endoscopic Sinus Surgery (FESS) Success Rate in New Delhi
Understanding the Endoscopic Sinus Surgery (FESS) success rate in New Delhi is vital for patients seeking relief from chronic sinusitis. Success rates for FESS are influenced by various factors, including the severity of the condition, presence of polyps, and individual patient health. New Delhi has established itself as a significant hub for advanced ENT procedures, with aggregated clinical data reflecting diverse outcomes based on specific treatment approaches.
Reviewing Endoscopic Sinus Surgery (FESS) outcomes in New Delhi provides valuable insights into treatment efficacy. Data from various medical centers in the city are evaluated to compare with national and international benchmarks. Outcomes for FESS typically vary depending on the extent of the disease, the specific surgical techniques employed, and the patient's overall health profile, underscoring the personalized nature of treatment.
Defining Success in Endoscopic Sinus Surgery (FESS)
For Endoscopic Sinus Surgery (FESS), "success" primarily means significant improvement in chronic sinus symptoms, leading to an enhanced quality of life. This includes better nasal breathing, reduced frequency of sinus infections, decreased facial pain or pressure, and a reduction in the need for medication. Success for FESS also encompasses long-term symptom control and a diminished rate of recurrence, distinguishing immediate relief from sustained benefits. The Endoscopic Sinus Surgery (FESS) recovery rate in New Delhi is often measured by the speed and completeness of symptom resolution post-procedure.
Endoscopic Sinus Surgery (FESS) Outcome Breakdown
Success rates for Endoscopic Sinus Surgery (FESS) vary depending on the specific surgical approach and underlying patient factors.
| Treatment Type / Category | Typical Use Case | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| Primary FESS for Chronic Rhinosinusitis | Initial surgery for persistent sinus inflammation without polyps. | 80%–95% | Substantial symptom reduction, improved sinus drainage. |
| FESS with Polyp Removal | Surgery for chronic rhinosinusitis with nasal polyps. | 70%–85% | Clearance of polyps, improved breathing, reduced inflammation. |
| Revision FESS | Follow-up surgery after previous unsuccessful sinus procedures. | 60%–75% | Further symptom improvement, addressing persistent issues. |
Endoscopic Sinus Surgery (FESS) Survival Rate by Age in New Delhi and Disease Severity
The long-term effectiveness, or Endoscopic Sinus Surgery (FESS) survival rate in New Delhi, can vary based on patient age and the complexity of their sinus condition. While "survival" for FESS refers to the sustained absence or significant reduction of symptoms rather than life expectancy, these long-term outcomes are crucial. Similarly, the stage wise Endoscopic Sinus Surgery (FESS) survival rate in New Delhi can be interpreted through the lens of disease severity, where more extensive disease may present different challenges to long-term symptom control.
| Age Group / Patient Category | Extent of Disease | Success Rate Range (%) |
|---|---|---|
| Children (Pediatric FESS) | Limited, localized sinus disease | 85%–90% |
| Adults (18-60 years) | Moderate chronic rhinosinusitis | 80%–95% |
| Elderly (Over 60 years) | Chronic sinusitis with comorbidities | 70%–85% |
| Adults with Severe Polyposis | Extensive nasal polyps requiring comprehensive FESS | 65%–80% |
New Delhi vs. Global FESS Success Rate Comparison
Endoscopic Sinus Surgery (FESS) success rate in New Delhi is generally comparable with international standards. Leading centers in the city often follow evidence-based protocols and utilize advanced technology, aligning their outcomes with those observed globally for similar patient populations and disease profiles.
| Country | Treatment Success Rate Range (%) |
|---|---|
| India (New Delhi) | 75%–90% |
| United States | 78%–92% |
| United Kingdom | 76%–90% |
| Germany | 77%–91% |
| Singapore | 79%–93% |
| United Arab Emirates | 74%–89% |
These rates are indicative and can vary significantly based on individual patient conditions and specific treatment approaches. They are not a guarantee of outcome for any individual.
Factors Influencing FESS Success Rate
- Severity and extent of the chronic sinusitis or polyps.
- Presence of co-existing conditions, such as allergies or asthma.
- Patient's overall health and immune status.
- Experience and specialization of the surgical team.
- Adherence to post-operative care and follow-up regimens.
- Smoking status or exposure to environmental irritants.
Data Sources & Methodology
- Aggregated clinical outcome data from multiple hospitals in New Delhi.
- Peer-reviewed medical literature and meta-analyses on FESS outcomes.
- National and international ENT specialty society guidelines and reports.
- Information from leading centers such as AIIMS, Tata Memorial Centre, and major institutes that follow evidence-based protocols.
Informed Choices for FESS Outcomes
Understanding Endoscopic Sinus Surgery (FESS) outcomes in New Delhi empowers patients to make informed healthcare decisions. Focus on evidence-based data and consult with specialists to gain clarity on realistic expectations for your specific condition.
Hospitals
NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.
Artemis Hospital
Sector 51, Gurugram, Haryana, India
Lokmanya Hospitals
Not Specified
White Lotus Hospital
766, SFS 3145, SFS Road, 7th Sector, HSR Layout, Bengaluru, Karnataka 560102, India
Institute of Brain and Spine (IBS Hospital)
Not Specified
Meet Our Medical Specialists
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
How DivinHeal Helps
We simplify your medical journey by providing comprehensive support and access to world-class healthcare.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Accredited Hospital Network
Access to JCI & NABH certified healthcare facilities.
Complete Travel Coordination
Hassle-free visa, stay, and local transport assistance.
24/7 Personal Care
Dedicated patient advisors supporting you at every step.
Journey Guidance
Full guidance from start to end of the patient treatment journey.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Everything you
need to know today
Browse through these common inquiries to better understand our patient-focused medical platform.
Yes, we work with a variety of insurance providers. Contact our team to verify your coverage.
Yes, we provide secure online consultations with experienced specialists.
Our care coordinators help match you with the most suitable specialist.
Absolutely. Your medical information is protected according to healthcare privacy standards.
Look at six things: accreditation (JCI or NABH), specialty depth, doctor credentials and experience, procedure-specific success rates, international patient support, and technology. DivinHeal's AI-driven matching evaluates every hospital in our accredited partner network on these dimensions and shortlists the best-fit options for your condition, budget, and country.
JCI (Joint Commission International) is the US-based global gold standard for hospital quality, recognised worldwide. NABH is India's national accreditation — accredited by ISQua, the same body that accredits JCI. Both signal independently verified safety and quality. Most of India's leading hospitals hold both.
Yes. All three welcome international patients through structured medical visa programs. India is the most established, treating patients from Africa, the Middle East, and South Asia at 60–80% lower cost. Thailand leads in cosmetic and dental care. The UAE is emerging in oncology and reproductive medicine.
Most patients save 50–80% on treatment costs. Heart bypass costs US $7,000–9,000 in India compared to $70,000–150,000 in the US. IVF costs $3,000–4,500 compared to $12,000–20,000 in the UK. Even after flights, visa, and accommodation, total savings remain 60–70%.
DivinHeal manages your entire non-medical journey: visa invitation letters, medical visa guidance, doctor appointments, teleconsultations, airport pickup, hospital-vetted accommodation for you and your attendant, language interpreters, local transport, cuisine preferences, and post-treatment follow-up — one dedicated coordinator from first enquiry to final follow-up.
You need a valid passport (6+ months validity), a medical visa (M-Visa for India — DivinHeal provides the hospital invitation letter), return flight tickets, recent medical reports and a doctor's referral, current prescription list, and proof of financial means. Any accompanying attendant needs their own passport and MX-Visa.
Still have more questions?
Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.